CJC-1295 DAC
SKU：cjc-1295-dac
Price：USD 60.00
Product information
CJC-1295 DAC is a modified growth-hormone-releasing-hormone analog carrying a drug-affinity-complex linker. Albumin attachment is a distinguishing feature compared with the non-DAC form. Experimental work examines growth-hormone-related signalling and its persistence under these conditions. Differences in signal duration provide a research comparison, rather than proof of a treatment benefit from this material.
Product specifications
- Also Known As
- DAC:GRF, CJC-1295 with DAC
- Type
- Synthetic GHRH analog with Drug Affinity Complex
- CAS Number
- 863288-34-0
- Molecular Weight
- 3,647.1 g/mol
- Amino Acids
- 30 (GHRH 1-29 analog)
- DAC Modification
- Maleimidopropionic acid on Lys8 → covalent albumin Cys34 binding
- Plasma Half-Life
- 5.8-8.1 days (albumin-bound)
- Form
- Lyophilized powder
- Purity
- ≥99% (HPLC verified)
- Testing
- Third-party HPLC, Mass Spec, Endotoxin
- Storage
- -20°C for up to 24 months
- Solubility
- Water-soluble
- Strength
- 5mg
- Molecular Formula
- C152H252N44O42
- Appearance
- White to off-white powder
Analysis report
CJC-1295 DAC 5mg · 5mg · CJC-DAC-101926-5
CJC-1295 DAC 5mg · 5mg · CJC-091126-5
CJC-1295 5mg WIH DAC · 5mg · K68WPF
Certificate of Analysis · Not provided · Not provided
CJC-1295 5mg WITH DAC · 5mg · SK090R
Research information
Read the full CJC-1295 DAC research monograph
Research overview
CJC-1295 DAC is a modified growth-hormone-releasing-hormone analog carrying a drug-affinity-complex linker. Albumin attachment is a distinguishing feature compared with the non-DAC form. Experimental work examines growth-hormone-related signalling and its persistence under these conditions. Differences in signal duration provide a research comparison, rather than proof of a treatment benefit from this material.